Park DS, Fishman GI. Navigating through a complex landscape: Scn10a and cardiac conduction. J Clin Invest, 2014,124(4):1460–1462
CAS
Article
PubMed
PubMed Central
Google Scholar
Lei M, Zhang H, Grace AA, et al. Scn5a and sinoatrial node pacemaker function. Cardiovasc Res, 2007,74(3): 356–365
CAS
Article
PubMed
Google Scholar
Goldin AL. Mechanisms of sodium channel inactivation. Curr Opin Neurobiol, 2003,13(3):284–290
CAS
Article
PubMed
Google Scholar
Wang Y, Mi J, Lu K, et al. Comparison of gating properties and use-dependent block of nav1.5 and nav1.7 channels by anti-arrhythmics mexiletine and lidocaine. PLoS One, 2015,10(6):e0128653
Article
PubMed
PubMed Central
Google Scholar
Rogart RB, Cribbs LL, Muglia LK, et al. Molecular cloning of a putative tetrodotoxin-resistant rat heart na+ channel isoform. Proc Natl Acad Sci USA, 1989,86(20): 8170–8174
CAS
Article
PubMed
PubMed Central
Google Scholar
Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the scn5a and herg genes have differential responses to na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation, 1995,92(12):3381–3386
CAS
Article
PubMed
Google Scholar
Clancy CE, Rudy Y. Na(+) channel mutation that causes both brugada and long-qt syndrome phenotypes: A simulation study of mechanism. Circulation, 2002,105(10): 1208–1213
Article
PubMed
PubMed Central
Google Scholar
Benito B, Brugada R, Perich RM, et al. A mutation in the sodium channel is responsible for the association of long qt syndrome and familial atrial fibrillation. Heart Rhythm, 2008,5(10):1434–1440
Article
PubMed
Google Scholar
Remme CA. Cardiac sodium channelopathy associated with scn5a mutations: Electrophysiological, molecular and genetic aspects. J Physiol, 2013,591(Pt17):4099–4116
CAS
Article
PubMed
PubMed Central
Google Scholar
Onkal R, Djamgoz MB. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: Clinical potential of neonatal nav1.5 in breast cancer. Eur J Pharmacol, 2009,625(1-3):206–219
CAS
Article
PubMed
Google Scholar
Itoh A, Saitoh T, Tani K, et al. Bisbenzylisoquinoline alkaloids from nelumbo nucifera. Chem Pharm Bull, 2011,59(8):947–951
CAS
Article
PubMed
Google Scholar
Yoon JS, Kim HM, Yadunandam AK, et al. Neferine isolated from nelumbo nucifera enhances anti-cancer activities in hep3b cells: Molecular mechanisms of cell cycle arrest, ER stress induced apoptosis and anti-angiogenic response. Phytomedicine, 2013,20(11): 1013–1022
CAS
Article
PubMed
Google Scholar
Gu DF, Li XL, Qi ZP, et al. Blockade of herg k+ channel by isoquinoline alkaloid neferine in the stable transfected hek293 cells. Naunyn Schmiedebergs Arch Pharmacol, 2009,380(2):143–151
CAS
Article
PubMed
Google Scholar
Guo Z. Electrophysiological effects of neferine against ischemic ventricular tachyarrhythmias. Zhonghua Xin Xue Guan Bing Za Zhi (Chinese), 1992,20(2):119–122, 134
CAS
Google Scholar
Li GR, Li XG, Lu FH. Effects of neferine on transmembrane potentials of guinea pig myocardium. Zhongguo Yao Li Xue Bao (Chinese), 1989,10(5):406–410
CAS
Google Scholar
Wang C, Chen YF, Quan XQ, et al. Effects of neferine on kv4.3 channels expressed in hek293 cells and ex vivo electrophysiology of rabbit hearts. Acta Pharmacol Sin, 2015,36(12):1451–1461
CAS
Article
PubMed
PubMed Central
Google Scholar
Huang Y, Zhao L, Bai Y, et al. Simultaneous determination of liensinine, isoliensinine and neferine from seed embryo of nelumbo nucifera gaertn. In rat plasma by a rapid hplc method and its application to a pharmacokinetic study. Arzneimittelforschung, 2011,61(6):347–352
CAS
PubMed
Google Scholar
Poulin H, Bruhova I, Timour Q, et al. Fluoxetine blocks nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics. Mol Pharmacol, 2014,86(4):378–389
Article
PubMed
PubMed Central
Google Scholar
Ziyadeh-Isleem A, Clatot J, Duchatelet S, et al. A truncating scn5a mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation. Heart Rhythm, 2014,11(6):1015–1023
Article
PubMed
PubMed Central
Google Scholar
Beyder A, Strege PR, Reyes S, et al. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel na(v)1.5: A novel mechanism of drug action. Circulation, 2012,125(22):2698–2706
CAS
Article
PubMed
PubMed Central
Google Scholar
Ju YK, Saint DA, Gage PW. Effects of lignocaine and quinidine on the persistent sodium current in rat ventricular myocytes. Br J Pharmacol, 1992,107(2):311–316
CAS
Article
PubMed
PubMed Central
Google Scholar
Kaufman ES. Quinidine in short qt syndrome: An old drug for a new disease. J Cardiovasc Electrophysiol, 2007,18(6):665–666
Article
PubMed
Google Scholar
Snyders DJ, Hondeghem LM. Effects of quinidine on the sodium current of guinea pig ventricular myocytes. Evidence for a drug-associated rested state with altered kinetics. Circ Res, 1990,66(2):565–579
CAS
PubMed
Google Scholar
Bahring R, Covarrubias M. Mechanisms of closed-state inactivation in voltage-gated ion channels. J Physiol, 2011,589(Pt3):461–479
Article
PubMed
Google Scholar
Wang H, Shi H, Zhang L, et al. Nicotine is a potent blocker of the cardiac a-type k(+) channels. Effects on cloned kv4.3 channels and native transient outward current. Circulation, 2000,102(10):1165–1171
CAS
PubMed
Google Scholar
Nishii N, Ogawa M, Morita H, et al. Scn5a mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with brugada syndrome. Circ J, 2010,74(12):2572–2578
CAS
Article
PubMed
Google Scholar
Giudicessi JR, Ye D, Tester DJ, et al. Transient outward current (i(to)) gain-of-function mutations in the kcnd3-encoded kv4.3 potassium channel and brugada syndrome. Heart Rhythm, 2011,8(7):1024–1032
Article
PubMed
PubMed Central
Google Scholar
Szel T, Antzelevitch C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of brugada syndrome. J Am Coll Cardiol, 2014,63(19):2037–2045
Article
PubMed
PubMed Central
Google Scholar
Mizusawa Y, Sakurada H, Nishizaki M, et al. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with brugada syndrome: Low-dose quinidine therapy as an adjunctive treatment. J Cardiovasc Pharmacol, 2006,47(3):359–364
CAS
PubMed
Google Scholar
He B, Soderlund DM. Human embryonic kidney (HEK293) cells express endogenous voltage-gated sodium currents and Nav 1.7 sodium channels. Neurosci Lett, 2010,469(2): 268–272
CAS
Article
PubMed
Google Scholar